Javier Escaned invites Justin Davies and Patrick Serruys to give an update on two trials presented at EuroPCR 2023: DEFINE-FLAIR 5-year follow-up and Reveal iFR.

DEFINE-FLAIR was the largest physiological study of its kind at the time, testing iFR in a non-inferior setting against FFR. The data...

Because multivessel disease raises many challenges, cardiac surgeon Lenard Conradi and interventional cardiologist Davide Capodanno discuss the biggest ones.

Is invasive coronary angiography really necessary? If revascularisation is required, which patient should be given a PCI rather than a CABG, and vice versa? What is state-of-the-art in surgery in...

Alessandro Sticchi interviews Pierre Deharo about the design and results of the study he presented during the ESC Congress 2023 in Amsterdam.
When comparing long-term outcomes of transcatheter edge-to-edge repair (TEER) versus isolated mitral valve repair surgery, the analysis revealed that cardiovascular death was lower among...

Aaysha Cader interviews Masahiro Natsuaki about the design and results of the STOPDAPT-3 trial which he presented during the ESC Congress 2023 in Amsterdam.

Prasugrel monotherapy after PCI with drug-eluting stents was not superior to dual-antiplatelet therapy (DAPT) for major bleeding but was non-inferior for cardiovascular events...

Alessandro Sticchi interviews Robert L. Smith & Firas Zahr about the CLASP IID Trial and Registry which they presented during the TCT Congress 2023 in San Francisco.

The PASCAL system proved effective in treating high-risk patients with symptomatic degenerative mitral regurgitation, meeting primary and secondary endpoints while improving...

Mirvat Alasnag interviews Susheel K. Kodali about the results of the TRISCEND II trial which he presented during the TCT Congress 2023 in San Francisco.

Data from the first 150 patients revealed that transcatheter valve replacement effectively improved tricuspid regurgitation and patient symptoms with low adverse events at...

Roxana Mehran, Marta Bande and Emanuele Barbato tackle the issue of gender equity: how to create a more equitable environment for women interventional cardiologists, and how to support women in the field of interventional cardiology as a whole. They also discuss the key drivers of change...

Nina Van Der Hoeven and Colin Berry seize the opportunity of meeting at the heart of EuroPCR 2023 to discuss the diagnostic approach of MINOCA. As they explain, everything is primarily determined in the cathlab, thanks to angiograms. Further investigations are then required to exclude other causes than...

Suhas Hardas, Anupam Jena and Rajneesh Kapoor discuss ultra-thin strut stent technology.

When do we really call the new-generation stents "ultra-thin strut strents"? Why do we need stents of this type? Which lesions, or which patients, will they be most useful and effective for?

Find out more about...

We have significant new data that highlights the long-lasting effectiveness of transcatheter devices, which brings forth a promising possibility of them competing with surgical valves in the next generation. Take part in a discussion with Bernard Prendergast and Raj Makkar as they analyze the data available so far...

Niels Van Royen and Lorenz Räber discuss a very emerging topic: the vulnerable plaque, and more specifically the related PECTUS Trial. They address the question of why vulnerable plaques should be detected and what can be done with the results, before looking at the study design...

EuroPCR – the 2023 edition – has been prepared with a new Core Team. Indeed, Jean Fajadet and William Wijns invited three new Course Directors to join them in this role at the end of last year. It was all part of a general reorganisation of PCR’s structure, during...

Deanna Khoo invites Paul Ong and Michael K. Y. Lee, the Principal Investigators of the study, to present the results of the BioFreedom Asian Registry, which focused on the management of STEMI patients in Asia.

Find out more about the study design, before discovering the main outcomes!

This interview...

Launched in December 2023 by our community through the ‘We CARE Alliance’ and co-funded by the EU4Health work programme, the mission of the RESIL-Card project is to ensure that essential healthcare services for people with cardiovascular (CV) diseases are maintained during crises. Specifically, the project aims to...

Nicola Ryan provides her take on the ALIGN AR trial which was presented by Vinod H. Thourani at TCT Congress 2023. The Align AR trial is a prospective single-arm investigation device exemption study assessing the safety and efficacy of the Trilogy transcatheter heart valve system in patients with...

Alex Sticchi provides his take on the results of the RIVER trial, which were presented by Pedro Gabriel Barros E Silva during the ESC 2023 congress in Amsterdam.

Rivaroxaban versus Warfarin in Patients with Bioprosthetic Valves According to Valvular Heart Disease Etiology, and Thrombotic and Bleeding Risks: Insights from...

Paris, France, 20-23 May 2025. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during the 2025 edition of EuroPCR. These trials were selected because of their design, results, and potential to impact practice, among them is the...

Quantitative coronary angiography-guidance versus intravascular ultrasound-guidance for drug-eluting stent implantation (GUIDE-DES trial): A multicenter, non-inferiority, randomised-controlled trial

Nicola Ryan provides her take on the final results of GUIDE-DES which were presented by Taeoh Kim during the ESC 2023 congress in Amsterdam.

Note the assumptions in this article are based on the presentation...

Nicola Ryan reports on the BIOFLOW DAPT trial results presented during the ESC 2023 Congress in Amsterdam by Marco Valgimigli and published in Circulation.

BIOFLOW-DAPT is an open-label randomised trial comparing the safety and efficacy of a biodegradable-polymer sirolimus-eluting stent with a durable-polymer zotarolimus-eluting stent in high-bleeding risk patients...